Items where authors include "Kankanala, J"

Article

Shaw, J, Gosein, R, Kalita, MM et al. (19 more authors) (2020) Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy. eLife, 9. e52555.

Scott, C, Kankanala, J, Foster, TL et al. (20 more authors) (2020) Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. PLOS Pathogens, 16 (8). e1008716. ISSN 1553-7366

Latham, AM, Kankanala, J, Fishwick, CWG et al. (1 more author) (2015) Identification of Receptor Tyrosine Kinase Inhibitors Using Cell Surface Biotinylation and Affinity Isolation. Methods in Molecular Biology, 1332. pp. 121-131. ISSN 1064-3745

Latham, AM, Kankanala, J, Fearnley, GW et al. (6 more authors) (2014) In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis. PLoS ONE, 9 (11). ARTN e110997. ISSN 1932-6203

Foster, TL, Thompson, GS, Kalverda, AP et al. (13 more authors) (2014) Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release. Hepatology, 59 (2). pp. 408-422. ISSN 0270-9139